Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers
- 21 October 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (42) , 16224-16229
- https://doi.org/10.1073/pnas.0808041105
Abstract
We have performed a genome-wide analysis of copy number changes in breast and colorectal tumors using approaches that can reliably detect homozygous deletions and amplifications. We found that the number of genes altered by major copy number changes, deletion of all copies or amplification to at least 12 copies per cell, averaged 17 per tumor. We have integrated these data with previous mutation analyses of the Reference Sequence genes in these same tumor types and have identified genes and cellular pathways affected by both copy number changes and point alterations. Pathways enriched for genetic alterations included those controlling cell adhesion, intracellular signaling, DNA topological change, and cell cycle control. These analyses provide an integrated view of copy number and sequencing alterations on a genome-wide scale and identify genes and pathways that could prove useful for cancer diagnosis and therapy.Keywords
This publication has 44 references indexed in Scilit:
- PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancerOncogene, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arraysOncogene, 2007
- Digital karyotypingNature Protocols, 2007
- Homozygous deletion scanning of the lung cancer genome at a 100‐kb resolutionGenes, Chromosomes and Cancer, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Mapping the Cancer GenomeScientific American, 2007
- A high-resolution survey of deletion polymorphism in the human genomeNature Genetics, 2005
- Cancer genes and the pathways they controlNature Medicine, 2004
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997